EUVIMEDAtrasti EUVIMED
Open access · CC BY-NC-ND 4.0

Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder

Su-Hyun Kim iD, Jieun Chung iD, Rosah May Palermo Payumo iD, Jae-Won Hyun, Ho Jin Kim iD

European Journal of Neurology · 2026

DOI: 10.1111/ene.70784 ↗

At a glance

Journal article in European Journal of Neurology, 2026. Written by Su-Hyun Kim and 4 co-authors. Institution: Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea. Major MEDLINE topics: Neuromyelitis Optica, Glial Fibrillary Acidic Protein. 12 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Cancer Center.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Objectives

Magnetic resonance imaging (MRI) is widely used to support relapse diagnosis in neuromyelitis optica spectrum disorder (NMOSD), yet some patients present with attack‐like symptoms without corresponding lesions. We assessed serum glial fibrillary acidic protein (sGFAP) levels in MRI‐negative attack‐like episodes.

Methods

We retrospectively analyzed aquaporin‐4‐IgG–positive NMOSD patients presenting with relapse‐like symptoms but without corresponding new MRI lesions. sGFAP was measured from stored serum collected at presentation and converted to demographic‐adjusted z ‐scores. A predefined attack‐associated threshold ( z ‐score ≥ 3.0) was based on prior work.

Results

We identified 39 MRI‐negative attack‐like episodes from 34 patients. Most episodes were clinically mild or subjective, with objective worsening observed in 23%. Eight episodes (21%) showed elevated sGFAP levels (median z ‐score 4.56 [1748 pg/mL]). Compared with episodes without elevated sGFAP, these episodes occurred closer to prior attacks (8 vs. 33 months) and more frequently met objective worsening criteria (50% vs. 16%). In all episodes with elevated sGFAP, remission samples showed normalization below the threshold.

Discussion

Marked sGFAP elevation in a subset of MRI‐negative episodes suggests that some events may represent relapse not captured by conventional imaging. sGFAP may serve as a complementary biomarker to support attack identification when clinical and MRI findings are inconclusive.

Subjects

MeSH terms (MEDLINE)

Neuromyelitis OpticaGlial Fibrillary Acidic ProteinHumansFemaleMagnetic Resonance ImagingAdultRetrospective StudiesMaleMiddle AgedBiomarkersAquaporin 4Recurrence

Author keywords

MRI‐negativeattack identificationneuromyelitis optica spectrum disorderrelapseserum glial fibrillary acidic protein

Substances

Glial Fibrillary Acidic ProteinBiomarkersAquaporin 4GFAP protein, humanAQP4 protein, human

Authors and institutions

  • Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea.

ORCID profiles: Su-Hyun Kim, Jieun Chung, Rosah May Palermo Payumo, Ho Jin Kim

Funding

  • National Cancer Center

Cite

APA

Kim, S. H., Chung, J., Payumo, R. M. P., Hyun, J. W., & Kim, H. J. (2026). Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder. European Journal of Neurology. https://doi.org/10.1111/ene.70784

Vancouver

Kim SH, Chung J, Payumo RMP, Hyun JW, Kim HJ. Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder. European Journal of Neurology. 2026. doi:10.1111/ene.70784

BibTeX
@article{Kim2026,
  author = {Kim, Su-Hyun and Chung, Jieun and Payumo, Rosah May Palermo and Hyun, Jae-Won and Kim, Ho Jin},
  title = {Blood Glial Fibrillary Acidic Protein in MRI ‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder},
  journal = {European Journal of Neurology},
  year = {2026},
  doi = {10.1111/ene.70784}
}
Start for free →